Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Anti-HIV Agents / adverse effects"'
Autor:
Newell Marie-Louise
Publikováno v:
Bulletin of the World Health Organization, Vol 79, Iss 12, Pp 1138-1144 (2001)
In June 2001 the United Nations Special Assembly on HIV/AIDS set reduction targets of 20% and 50% for the numbers of children newly infected with HIV by 2005 and 2010 respectively. Are these targets achievable? Antiretroviral monotherapy during pregn
Externí odkaz:
https://doaj.org/article/e8d0ef77bb4a4a998c4c832837f109c4
Autor:
Greenberg, Lauren, Ryom, Lene, Wandeler, Gilles, Grabmeier-Pfistershammer, Katharina, Öllinger, Angela, Neesgaard, Bastian, Stephan, Christoph, Calmy, Alexandra, Rauch, Andri, Castagna, Antonella, Spagnuolo, Vincenzo, Johnson, Margaret, Stingone, Christof, Mussini, Cristina, De Wit, Stéphane, Necsoi, Coca, Campins, Antoni A., Pradier, Christian, Stecher, Melanie, Wasmuth, Jan-Christian, Monforte, Antonella dʼArminio, Law, Matthew, Puhr, Rainer, Chkhartishvilli, Nikoloz, Tsertsvadze, Tengiz, Garges, Harmony, Thorpe, David, Lundgren, Jens D., Peters, Lars, Bansi-Matharu, Loveleen, Mocroft, Amanda, RESPOND Study Group
Publikováno v:
Greenberg, Lauren; Ryom, Lene; Wandeler, Gilles; Grabmeier-Pfistershammer, Katharina; Öllinger, Angela; Neesgaard, Bastian; Stephan, Christoph; Calmy, Alexandra; Rauch, Andri; Castagna, Antonella; Spagnuolo, Vincenzo; Johnson, Margaret; Stingone, Christof; Mussini, Cristina; De Wit, Stéphane; Necsoi, Coca; Campins, Antoni A; Pradier, Christian; Stecher, Melanie; Wasmuth, Jan-Christian; ... (2020). Uptake and discontinuation of integrase inhibitors (INSTIs) in a large cohort setting. Journal of acquired immune deficiency syndromes JAIDS, 83(3), pp. 240-250. Wolters Kluwer Health 10.1097/QAI.0000000000002250
Journal of Acquired Immune Deficiency Syndromes, Vol. 83, No 3 (2020) pp. 240-250
Journal of Acquired Immune Deficiency Syndromes, Vol. 83, No 3 (2020) pp. 240-250
BACKGROUND: Despite increased integrase strand transfer inhibitor (INSTI) use, limited large-scale, real-life data exists on INSTI uptake and discontinuation. SETTING: International multicohort collaboration. METHODS: RESPOND participants starting do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e57720ea1f0f49399c3e213c548f4eed
Autor:
Moraes, Rodrigo, Ferreira, Maria, Vaz, Rita, Coelho, Inês, Pinheiro, Guiomar, Gonçalves, João, França, Margarida, Almeida, Isabel
Publikováno v:
Medicina Interna, Volume: 26, Issue: 1, Pages: 14-20, Published: MAR 2019
Introdução: O dolutegravir apresenta-se como opção terapêutica com elevados níveis de eficácia para doentes naive ou experimentados, nomeadamente na simplificação de regimes terapêuticos e com um bom perfil de interações. Os resultados do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99a43376a673460acf8522fa74908b75
http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-671X2019000100005&lng=en&tlng=en
http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-671X2019000100005&lng=en&tlng=en
Autor:
Ursula Winterfeld, Christian R. Kahlert, Claire Thorne, Angèle Gayet-Ageron, Lars Naver, Heather Bailey
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes, Vol. 80, No 3 (2019) pp. 316-324
To investigate the association between efavirenz (EFV) use during conception or first trimester (T1) of pregnancy and the occurrence of birth defects.Seven observational studies of pregnant HIV-positive women across 13 European countries and Thailand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946322932354d53a45f0adce7aa68533
https://archive-ouverte.unige.ch/unige:143240
https://archive-ouverte.unige.ch/unige:143240
Autor:
Pedro Cahn, Juan Sierra Madero, José Ramón Arribas, Andrea Antinori, Roberto Ortiz, Amanda E Clarke, Chien-Ching Hung, Jürgen K Rockstroh, Pierre-Marie Girard, Jörg Sievers, Choy Man, Alexander Currie, Mark Underwood, Allan R Tenorio, Keith Pappa, Brian Wynne, Anna Fettiplace, Martin Gartland, Michael Aboud, Kimberly Smith, Lidia Cassetti, Daniel David, Laura Figueras, Marcelo Losso, Gustavo Lopardo, Sergio Lupo, Norma Porteiro, Marisa Sánchez, Mark Bloch, David Cooper, Robert Finlayson, Anthony Kelleher, Kenneth Koh, David Lewis, James McMahon, Richard Moore, Norman Roth, Matthew Shields, Stephane De Wit, Eric Florence, Jean-Christophe Goffard, Remy Demeester, Patrick Lacor, Bernard Vandercam, Linos Vandekerckhove, Jonathan Angel, Jean-Guy Baril, Brian Conway, Alexandra De Pokomandy, Jason Szabo, Sharon Walmsley, Olivier Bouchaud, Christian Chidiac, Pierre Delobel, Cecile Goujard, Christine Katlama, Jean-Michel Molina, Gilles Pialoux, Patrick Philibert, Johannes Bogner, Stefan Esser, Ivanka Krznaric, Clara Lehmann, Christoph Spinner, Hans-Jurgen Stellbrink, Christoph Stephan, Albrecht Stoehr, Enrico Barchi, Pietro Caramello, Francesco Castelli, Anna Maria Cattelan, Antonella D'Arminio Monforte, Antonio Di Biagio, Giovanni Di Perri, Andrea Gori, Franco Maggiolo, Barbara Menzaghi, Guglielmo Migliorino, Cristina Mussini, Giovanni Penco, Massimo Puoti, Giuliano Rizzardini, Roberto Gulminetti, Adriano Lazzarin, Tiziano Quirino, Laura Sighinolfi, Pierluigi Viale, Gerardo Amaya Tapia, Jaime Andrade Villanueva, Enrique R Granados Reyes, Alma Perez Rios, Mario Santoscoy Gomez, Jan Den Hollander, Bart Rijnders, José A Hidalgo, Luis Hercilla Vasquez, Luis Illescas, Anita Olczak, Kamal Mansinho, Patricia Paula Correia Pacheco, Eugénio Teófilo, Jose Saraiva da Cunha, Rui Sarmento e Castro, Rosário Serrão, Manuela Arbune, Cristian Jianu, Anca Oprea, Liliana Preotescu, Liviu-Jany Prisacariu, Elena Belonosova, Olga Borodkina, Oxana Chernova, Natalia Gankina, Svetlana Kizhlo, Valeriy Kulagin, Nadezhda Kurina, Firaya Nagimova, Vadim Pokrovsky, Elena Ryamova, Evgeny Voronin, Alexey Yakovlev, Richard Kaplan, Sun Hee Lee, Shin-Woo Kim, Sang-Il Kim, Woo Joo Kim, Antonio Antela Lopez, Jose L Casado Osorio, Manuel A Castaño Carracedo, Ignacio De Los Santos Gil, Vicente Estrada Perez, Vicenç Falco Ferrer, Luis Force, Maria Jose Galinda Puerto, Miguel Garcia Deltoro, Josep M Gatell, Miguel A Goenaga Sanchez, Ana González Cordón, Hernando Knobel, Juan Carlos Lopez Bernaldo de Quiros, Juan E Losa Garcia, Mar Masia, Marta Montero-Alsonso, Antonio Ocampo Hermida, Juan Pasquau Liaño, Joaquin Portilla Sogorb, Federico Pulido Ortega, Antonio Rivera Roman, Jose Ramon Santos Fernandez, Rafael Torres Perea, Jesus Troya Garcia, Pompeyo Viciana Fernandez, Alexandra Calmy, Christoph Hauser, Jan Fehr, Shu-Hsing Cheng, Wen-Chien Ko, Hsi-Hsun Lin, Po-Liang Lu, Yu-Ting Tseng, Ning-Chi Wang, Wing-Wai Wong, Chia-Jui Yang, Roberto Arduino, Paul Benson, Mezgebe Berhe, Fritz Bredeek, Cynthia Brinson, Thomas Campbell, Gordon Crofoot, Douglas Cunningham, Edwin DeJesus, Robin Dretler, Joseph Eron, Kenneth Fife, Carl Fichtenbaum, Jason Flamm, Deborah Goldstein, Samir Gupta, Debbie Hagins, Margaret Hoffman-Terry, Dushyantha Jayaweera, Clifford Kinder, Daniel Klein, Cheryl McDonald, Anthony Mills, Ronald Nahass, Olayemi Osiyemi, Edgar Overton, David Parks, David Prelutsky, Moti Ramgopal, Shannon Schrader, Beverly Sha, Gary Simon, James Sims, Daniel Skiest, Jihad Slim, Karen Tashima, Blair Thedinger, Brian Gazzard, Julie Fox, Margaret Johnson, Stephen Kegg, Saye Khoo, Charles Mazhude, Chloe Orkin, Gabriel Schembri, Andrew Ustianowski
Publikováno v:
The Lancet, 393(10167), 143-155. Elsevier Ltd.
Summary Background Effective two-drug regimens could decrease long-term drug exposure and toxicity with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and safety of a two-drug regimen compared with a three-drug regime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad70b60db548619c808fac0879d6106
https://hdl.handle.net/11380/1221490
https://hdl.handle.net/11380/1221490
Publikováno v:
Urological Research, Vol. 34, No 4 (2006) pp. 288-9
We describe the first case of efavirenz-induced urolithiasis in a 47-year-old HIV-positive patient. Urinary obstruction led to pyelonephritis and septic shock, requiring emergency ureteral catheterisation. The subsequent clinical course was favourabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e368879273eb74924b548d13a6e96cb4
http://doc.rero.ch/record/318918/files/240_2006_Article_52.pdf
http://doc.rero.ch/record/318918/files/240_2006_Article_52.pdf
Autor:
Mark Haas, Luan D. Truong, Martin Zeier, David C. Wheeler, Ikechi G. Okpechi, Corinne I. Bagnis, Nicola Wearne, Mignon McCulloch, Michelle M. Estrella, Michael W. Ross, Ifeoma Ulasi, June Fabian, Gloria Ashuntantang, Fredric O. Finkelstein, Liffert Vogt, Ali K. Abu-Alfa, Cynthia C. Nast, Bruce M. Hendry, Paul L. Kimmel, Christopher P. Larsen, Isabelle Brocheriou, Raj Bhimma, Arthur H. Cohen, Charles R. Swanepoel, Lawrence Y. Agodoa, Lisa Hamzah, Karen Cohen, H. Terence Cook, Sophie de Seigneux, Pulane Mosiane, Frank A. Post, J. Charles Jennette, Mary E. Klotman, Vivette D. D'Agati, Lene Ryom, Cheryl A. Winkler, Saraladevi Naicker, Avi Z. Rosenberg, Paul E. Klotman, Dwomoa Adu, Michael Cheung, Valentine Imonje, Fatiu A Arogundade, Mohamed G. Atta, Patricio E. Ray, Christina M. Wyatt, Agnes B. Fogo, Wolfgang C. Winkelmayer, Charles E. Alpers
Publikováno v:
Kidney International, Vol. 93, No 3 (2018) pp. 545-559
Kidney international, 93(3), 753-760. Nature Publishing Group
Kidney international, 93(3), 753-760. Nature Publishing Group
HIV-positive individuals are at increased risk for kidney disease, including HIV-associated nephropathy, non-collapsing focal segmental glomerulosclerosis, immune-complex kidney disease, and comorbid kidney disease, as well as kidney injury resulting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::706e991f7fdae51d5e515c50e061bae7
https://archive-ouverte.unige.ch/unige:150711
https://archive-ouverte.unige.ch/unige:150711
Autor:
Raphael Mohr, Christoph Boesecke, Evrim Anadol, Jürgen K. Rockstroh, Carolynne Schwarze-Zander, Jonel Trebicka, Jan-Christian Wasmuth, Kristina Lust
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0191118 (2018)
PLoS ONE
Anadol, E, Lust, K, Boesecke, C, Schwarze-Zander, C, Mohr, R, Wasmuth, J-C, Rockstroh, J K & Trebicka, J 2018, ' Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients ', PLOS ONE, vol. 13, no. 1, e0191118 . https://doi.org/10.1371/journal.pone.0191118
PLoS ONE
Anadol, E, Lust, K, Boesecke, C, Schwarze-Zander, C, Mohr, R, Wasmuth, J-C, Rockstroh, J K & Trebicka, J 2018, ' Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients ', PLOS ONE, vol. 13, no. 1, e0191118 . https://doi.org/10.1371/journal.pone.0191118
INTRODUCTION: Combined antiretroviral therapy (cART) has improved survival in HIV-patients. While the first antiretrovirals, which became available in particular D-drugs (especially didanosine and stavudine) and unboosted protease inhibitors, may imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e5633d0e64e739d992590ca1bfb434e
http://europepmc.org/articles/PMC5773180?pdf=render
http://europepmc.org/articles/PMC5773180?pdf=render
Autor:
Huldrych F. Günthard, Manuel Battegay, Enos Bernasconi, Stefan Erb, Alexandra Calmy, Pietro Vernazza, L Elzi, Hansjakob Furrer, Matthias Cavassini
Publikováno v:
Elzi, Luigia; Erb, Stefan; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Vernazza, Pietro; Günthard, Huldrych; Bernasconi, Enos; Battegay, Manuel (2017). Adverse events of raltegravir and dolutegravir. AIDS, 31(13), pp. 1853-1858. Lippincott Williams & Wilkins 10.1097/QAD.0000000000001590
AIDS, vol. 31, no. 13, pp. 1853-1858
AIDS (London, England)
AIDS, Vol. 31, No 13 (2017) pp. 1853-1858
AIDS, vol. 31, no. 13, pp. 1853-1858
AIDS (London, England)
AIDS, Vol. 31, No 13 (2017) pp. 1853-1858
OBJECTIVE To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. DESIGN Prospective cohort study. METHODS All antiretroviral therapy (ART)-naive and ART-experienced HIV-infected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c07bb325d96b7974f6c2d69cf92e7e
https://boris.unibe.ch/104861/1/00002030-201708240-00010.pdf
https://boris.unibe.ch/104861/1/00002030-201708240-00010.pdf
Autor:
Wang, Qing, Young, Jim, Bernasconi, Enos, Cavassini, Matthias, Vernazza, Pietro, Hirschel, Bernard, Weber, Rainer, Furrer, Hansjakob, Stoeckle, Marcel, Bucher, Heiner C, Fux, Christoph, Martinez De Tejada Weber, Begona
Publikováno v:
Antiviral Therapy, Vol. 18, No 3 (2013) pp. 337-44
Background Here, we aimed to determine the prevalence of erectile dysfunction (ED) among HIV-infected men and its association with components of antiretroviral therapy. Methods Cross-sectional data on sexual dysfunction were collected in the Swiss HI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be700940d28999a5c73bd026ecb1cd2
https://doi.org/10.3851/imp2372
https://doi.org/10.3851/imp2372